Roche to gain gut disease drug in $7.1B deal for Roivant subsidiary
BioPharma
Source: biopharmadive.com
Page 42 - Roivant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Roivant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Roivant Sciences Today - Breaking & Trending Today
Roche to Pay $7.1B to Get Contender in Tight Inflammatory Bowel Disease Race
Roche’s Telavant acquisition comes as the Roivant Sciences subsidiary prepares its main asset for Phase 3 testing in ulcerative colitis. The antibody drug candidate blocks a novel target for inflammation and fibrosis that’s also the focus of clinical-stage programs of other big pharma companies.
Source: medcitynews.com
Trending : Roche to Buy Telavant From Roivant and Pfizer -October 23, 2023 at 03:27 pm EDT
1504 ET -- Roche Holding and Pfizer are among the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. Roche agreed to buy Telavant Holdings...
Source: marketscreener.com
:max_bytes(150000):strip_icc()/GettyImages-1365908035-7aabb794cb0f413da9cd46ebbac2f2ec.jpg)
Roivant Sciences Sells Joint Venture With Pfizer to Roche for $7.1 Billion
Roivant agreed to sell its Telavant joint venture with Pfizer to Roche for $7.1 billion.
Source: investopedia.com
Vivek Ramaswamy brings presidential campaign to Fort Madison
“The is our 1776 moment. This is our time to answer what it means to be an American.”
Source: mississippivalleypublishing.com